菜 (Spinacia oleracea L.) 黄在消化过程中被水解,它们的生物可访问性受到比原材料内容更强大的遗传控制
Michael P Dzakovich1, Alvin L Tak1, Elaine A Le1
1USDA-ARS Children's Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, 1100 Bates Ave., Houston, TX 77030, USA.
Foods (Basel, Switzerland)
|December 30, 2025
概括
菜的黄酸受环境和遗传学的影响. 生物可访问性是一种遗传性特征,但一些黄在消化过程中降解,影响其健康益处.
科学领域:
- 植物生物化学 植物生物化学
- 营养科学 营养科学
- 农业遗传学 农业遗传学
背景情况:
- 菜 (Spinacia oleracea L.) 富含独特的黄胺,可能有助于其健康益处.
- 关于这些菜黄的遗传多样性,生物可访问性和遗传性,知识有限.
- 了解这些因素对于优化菜的营养价值至关重要.
研究的目的:
- 为了研究基因多样性和环境对菜中的黄类度的影响.
- 评估黄类生物可获得性的遗传性及其与原材料含量的关系.
- 在模拟的消化条件下评估菜黄酸的稳定性.
主要方法:
- 在受控条件下种植了30种加入 (F1和开放授粉) 的菜多样性面板.
- 使用先进的分析技术进行了39种黄类素的量化.
- 评估了生物可访问性,并在模拟消化后分析了黄胺稳定性.
主要成果:
- 黄胺度受到环境因素的显著影响,生物合成途径可能有差异.
- 开放授粉和F1菜品种在较小的黄胺度方面表现出不同的特征.
- 绝对生物可访问性的广义遗传性高于原材料的遗传性,这表明它具有繁殖潜力.
结论:
- 菜的黄类生物合成和生物可访问性是复杂的,并且依赖于环境.
- 生物可访问性是一种遗传性特征,为植物育种者提供了目标.
- 在消化过程中发生了黄酸的显著降解,影响了体内生物可用性.
相关概念视频
Factors Influencing Bioavailability: First-Pass Elimination
7.8K
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
7.8K
Bioavailability: Influencing Factors
304
Bioavailability refers to the extent and rate at which a drug reaches systemic circulation in its active form. Extent refers to the amount of the drug that makes it into circulation, while rate is the speed at which it enters circulation. It is influenced by several factors critical for optimizing drug formulations, dosing regimens, and therapeutic outcomes.Physicochemical properties of drugs and formulationsThe solubility, stability, and dissolution rate of a drug significantly impact its...
304
Oxidation of Phenols to Quinones
4.4K
In the presence of oxidizing agents, phenols are oxidized to quinones. Quinones can be easily reduced back to phenols using mild reducing agents. The electron-donating hydroxyl group enhances the reactivity of the aromatic ring, enabling oxidation of the ring even in the absence of an α hydrogen.
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
4.4K
Bioavailability Study Design: Absolute Versus Relative Bioavailability
261
Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...
261
Bioavailability: Overview
3.9K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
3.9K
Bioavailability: Overview
310
Bioavailability refers to the proportion of an administered drug that reaches the systemic circulation in its active, unaltered form. It is a crucial pharmacokinetic parameter that determines the effectiveness of a drug in achieving its intended therapeutic outcomes. The route of administration significantly influences bioavailability, with intravenous administration achieving 100% bioavailability as the drug directly enters the bloodstream. In contrast, oral administration often results in...
310


